Chronic myeloid leukemia: Global impact from a local laboratory. Radich, J. P. Cancer, 123(14):2594–2596, July, 2017. doi bibtex @article{radich_chronic_2017,
title = {Chronic myeloid leukemia: {Global} impact from a local laboratory},
volume = {123},
issn = {1097-0142},
shorttitle = {Chronic myeloid leukemia},
doi = {10.1002/cncr.30776},
language = {eng},
number = {14},
journal = {Cancer},
author = {Radich, Jerald P.},
month = jul,
year = {2017},
pmid = {28586121},
keywords = {Fusion Proteins, bcr-abl, Humans, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Prognosis, Protein Kinase Inhibitors},
pages = {2594--2596},
}
Downloads: 0
{"_id":"3o65jEybmNgan7NYP","bibbaseid":"radich-chronicmyeloidleukemiaglobalimpactfromalocallaboratory-2017","author_short":["Radich, J. P."],"bibdata":{"bibtype":"article","type":"article","title":"Chronic myeloid leukemia: Global impact from a local laboratory","volume":"123","issn":"1097-0142","shorttitle":"Chronic myeloid leukemia","doi":"10.1002/cncr.30776","language":"eng","number":"14","journal":"Cancer","author":[{"propositions":[],"lastnames":["Radich"],"firstnames":["Jerald","P."],"suffixes":[]}],"month":"July","year":"2017","pmid":"28586121","keywords":"Fusion Proteins, bcr-abl, Humans, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Prognosis, Protein Kinase Inhibitors","pages":"2594–2596","bibtex":"@article{radich_chronic_2017,\n\ttitle = {Chronic myeloid leukemia: {Global} impact from a local laboratory},\n\tvolume = {123},\n\tissn = {1097-0142},\n\tshorttitle = {Chronic myeloid leukemia},\n\tdoi = {10.1002/cncr.30776},\n\tlanguage = {eng},\n\tnumber = {14},\n\tjournal = {Cancer},\n\tauthor = {Radich, Jerald P.},\n\tmonth = jul,\n\tyear = {2017},\n\tpmid = {28586121},\n\tkeywords = {Fusion Proteins, bcr-abl, Humans, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Prognosis, Protein Kinase Inhibitors},\n\tpages = {2594--2596},\n}\n\n","author_short":["Radich, J. P."],"key":"radich_chronic_2017","id":"radich_chronic_2017","bibbaseid":"radich-chronicmyeloidleukemiaglobalimpactfromalocallaboratory-2017","role":"author","urls":{},"keyword":["Fusion Proteins","bcr-abl","Humans","Leukemia","Myelogenous","Chronic","BCR-ABL Positive","Prognosis","Protein Kinase Inhibitors"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://api.zotero.org/users/16293305/collections/HMMCWKCD/items?key=kgBL1PVv7i72QlzbAHKlcP6L&format=bibtex&limit=100","dataSources":["nHWD9p4y9JH6KHWbk","XX9KPWuC2QeLzj9mN"],"keywords":["fusion proteins","bcr-abl","humans","leukemia","myelogenous","chronic","bcr-abl positive","prognosis","protein kinase inhibitors"],"search_terms":["chronic","myeloid","leukemia","global","impact","local","laboratory","radich"],"title":"Chronic myeloid leukemia: Global impact from a local laboratory","year":2017}